Maravai LifeSciences Holdings Inc (MRVI)
7.37
+0.07
(+0.96%)
USD |
NASDAQ |
Apr 22, 16:00
7.35
-0.02
(-0.27%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Financing (TTM): -61.09M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -61.09M |
| September 30, 2023 | -127.68M |
| June 30, 2023 | -165.91M |
| March 31, 2023 | -166.18M |
| December 31, 2022 | -187.50M |
| September 30, 2022 | -170.96M |
| June 30, 2022 | -184.80M |
| Date | Value |
|---|---|
| March 31, 2022 | -175.51M |
| December 31, 2021 | -159.05M |
| September 30, 2021 | -68.80M |
| June 30, 2021 | -18.46M |
| March 31, 2021 | 14.82M |
| December 31, 2020 | 53.21M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-187.50M
Minimum
Dec 2022
53.21M
Maximum
Dec 2020
-109.07M
Average
-159.05M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
| ModivCare Inc | 113.07M |
| Dyadic International Inc | 0.00 |
| Enveric Biosciences Inc | -1.343M |
| Monopar Therapeutics Inc | 2.027M |
| SeaStar Medical Holding Corp | 10.41M |